Sutaria Saumya 4

What Happened
Saumya Sutaria, CEO and director of Tenet Healthcare Corporation (THC), had 18,242 restricted stock units (RSUs) vest and convert into common shares on February 24, 2026. The Form 4 reports 18,242 shares acquired via conversion of derivatives and an equal 18,242 shares disposed at $0.00. The entries reflect RSU settlement on vesting rather than an open‑market purchase or cash sale.

Key Details

• Transaction date: February 24, 2026. Filing date: February 26, 2026 (filed promptly after the transaction).
• Acquired: 18,242 shares via conversion of derivative (code M). Acquisition price: N/A (RSU conversion).
• Disposed: 18,242 shares at $0.00 (reported as disposition of derivative). Reported dollar amount: $0.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Relevant footnotes:
  • F1: RSUs convert 1-for-1 into common stock.
  • F2: These RSUs were granted under the 2019 Stock Incentive Plan on Feb 24, 2025 and vest in three equal annual installments; the first 1/3 vested on Feb 24, 2026.
  • F3: Time‑based RSUs are settled in shares upon vesting.
• Timeliness: Filing appears timely (filed two days after the vesting date).

Context
This filing documents routine RSU vesting and share settlement rather than a discretionary market buy or sell. The matching disposition at $0.00 is commonly how companies report shares withheld or otherwise not delivered to satisfy tax withholding or similar obligations upon vesting; the Form 4 here does not show a cash sale. For retail investors, vesting events are standard compensation actions and do not by themselves signal a change in executive conviction.